Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Yang, Yu-Jiea; b; 1 | Bu, Lu-Lua; e; 1 | Shen, Conga; 1 | Ge, Jing-Jiec | He, Shu-Jina | Yu, Hui-Linga | Tang, Yi-Lina | Jue, Zhaoa | Sun, Yi-Mina | Yu, Wen-Boa | Zuo, Chuan-Taoc | Wu, Jian-Juna | Wang, Jiana; * | Liu, Feng-Taoa; d; *
Affiliations: [a] Department of Neurology & National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China | [b] Institute of Biomedical Science, Fudan University, Shanghai, China | [c] PET Center, Fudan University, Shanghai, China | [d] Department of Neurology, Huashan Hospital North, Fudan University, Shanghai, China | [e] Department of Neurology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China
Correspondence: [*] Correspondence to: Feng-Tao Liu or Jian Wang, Department of Neurology, Huashan Hospital Affiliated to Fudan University, 12 Wulumuqi Middle Road, Shanghai, 200040. P.R. China. Tel.: +86 13917604896; Fax: +86 21 52888163; E-mails: liufengtao@fudan.edu.cn or wangjian336@hotmail.com.
Note: [1] These authors contributed equally to this work.
Abstract: Background:Parkinson’s disease (PD) is the second most common neurodegenerative disorder, but the disease-modifying therapies focusing on the core pathological changes are still unavailable. Rho-associated protein kinase (ROCK) has been suggested as a promising target for developing neuroprotective therapies in PD. Objective:We aimed to explore the promotion of α-synuclein (α-syn) clearance in a rat model. Methods:In a rat model induced by unilateral injection of adeno-associated virus of serotype 9 (AAV9) expressing A53T α-syn (AAV9-A53T-α-syn) into the right substantia nigra, we aimed to investigate whether Fasudil could promote α-syn clearance and thereby attenuate motor impairments and dopaminergic deficits. Results:In our study, treatment with Fasudil (5 mg/kg rat weight/day) for 8 weeks significantly improved the motor deficits in the Cylinder and Rotarod tests. In the in vivo positron emission tomography imaging with the ligand 18F-dihydrotetrabenazine, Fasudil significantly enhanced the dopaminergic imaging in the injected striatum of the rat model (p < 0.05 vs. vehicle group, p < 0.01 vs. left striatum in Fasudil group). The following mechanistic study confirmed that Fasudil could promote the autophagic clearance of α-syn by Becline 1 and Akt/mTOR pathways. Conclusion:Our study suggested that Fasudil, the ROCK2 inhibitor, could attenuate the anatomical and behavioral lesions in the Parkinsonian rat model by autophagy activation. Our results identify Fasudil as a drug with high translational potential as disease-modifying treatment for PD and other synucleinopathies.
Keywords: Fasudil, A53T α-synuclein, Parkinson’s disease, macroautophagy, vesicular monoamine transporter 2, positron emission tomography
DOI: 10.3233/JPD-191909
Journal: Journal of Parkinson's Disease, vol. 10, no. 3, pp. 969-979, 2020
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl